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Abstract 
A High Performance liquid chromatographic method was developed for the determination of Cephalosporins like 
as: Cefuroxime axetil, Cefixime trihydrate, in pharmaceutical dosage forms. Isocratic separation was performed 
on an Enable C18 column (250 mm x 4.6 mm, 5.0µm) using Triethylamine: Methanol: Acetonitrile: Ultra Pure 
Water (2: 10: 20: 68 v/v%) as the mobile phase at a flow rate of 1.0 ml/min. The PDA detection wavelength was 
set at 265nm. The linearity was observed over a concentration range of 0.1–80 µg/ml for HPLC method (correlation 
coefficient=0.999). The developed methods were validated according to ICH guidelines. The relative standard 
deviation values for the method precision studies were < 2%, and the accuracy was > 99%. The developed method 
was used successfully for the determination of Cefuroxime axetil, Cefixime trihydrate, in Capsule, Tablet and  dry 
syrup formulations. 
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1. Introduction 
Cefuroxime axetil, (CA): 1-Hydroxyethyl (6R,7R)-7-[2-(2-furyl)glyoxylamido]-3-(hydroxymethyl)-8-oxo-5-thia-
1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (Fig. 1) is a second generation cephalosporin antibiotic [1].  
Cefixime trihydrate, (CT): (6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-
azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate (Fig. 2) is a third generation cephalosporin antibiotic [1].  
 
 
  
 
 
 
 
(Fig. 1)                                                                                       (Fig. 2) 
It is used in the treatment of susceptible infections of the respiratory tract, urinary tract, and skin. 
CF, CT have been found to reduce the corrosion of mild steel in hydrochloric acid solution [2]. According 
to literature surveys, there are different analytical methods reported for the determination of CF, CT. It includes 
UV-Visible spectroscopy [3–12], chemiluminescence [13], near infrared spectroscopy [14], potentiometry [15], 
polarography [16, 17], HPLC [18–26], gel filtration chromatography [27], HPLC [28], capillary zone 
electrophoresis [29], LC-MS [30, 31], and MS [32] methods. But no analytical methods are reported for the 
determination of CF, CT in dry syrup formulation using the mobile phase Triethylamine: Methanol: Acetonitrile: 
Ultra Pure Water (2: 10: 20: 68 v/v%) by HPLC (High Performance liquid chromatography). So a successful 
attempt was made to develop and validate a fast, simple, precise, and accurate HPLC method for the determination 
of CF, CT in Capsule, Tablet and Syrup formulation. Specificity and stability parameters for the drug were assessed 
according to ICH [33]. 
 
2. Experimental and Chemical Reagents 
Cefuroxime axetil (CA), Cefixime trihydrate (CT); (purity of all > 99.9%) was obtained as a gift sample from 
Parabolic Pharmaceuticals Ltd., India. Methanol (Merck Ltd., Mumbai, India) was of HPLC grade. Analytical 
grade Methanol, Acetonitrile, Triethylamine (Merck GmpH). The Ultra Pure water for HPLC was obtained by 
using the TKA Water Purification System, Germany. The Capsule formulation (CT) containing 400 mg\Cap. The 
Tablet formulation (CF) containing 500mg\Tab. The dry Syrup formulation (CF),(CT)containing 125mg\5mL, 
250mg\5mL,100mg\5mL, 200mg\5mL, was bought from the local market. 
 
3. Instrumention 
Quantitative HPLC was performed on a binary gradient with MERCK-HITACHI Prominence La Chrom pumps, 
with a 20 µl sample injection loop (Auto) and L-2455 PDA detector. The signal was recorded and integrated using 
EZ Chrom Software. An Enable C18, (250 mm × 4.6 mm i.d. particle size 5 µm) was used for separation. 
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Chromatographic analysis was carried out at ambient temperature on the column using the Triethylamine: 
Methanol: Acetonitrile: Ultra Pure Water (2: 10: 20: 68 v/v%) as the mobile phase at a flow rate of 1.0 ml/min in 
isocratic mode. The PDA detection was carried out at 265 nm.  
 
4. Preparation of Standard and Sample Solution 
Standard stock solutions of CF, CT were prepared by transferring 100 mg of the drug into two separate 100 ml 
volumetric flasks having 10 ml of diluents and were ultrasonicated for 5 minutes. Finally the volume was made 
up with suitable diluents, which gave 1000 µg\mL solutions. Powder (Capsule, Tablet and dry Syrup) equivalent 
to 100 mg of CF, CT was accurately measured and transferred into two separate 100 ml volumetric flasks, 
containing 10 ml of diluents and ultrasonicated for 20 minutes; the volume was made up and mixed well. Solutions 
were filtered by a 0.2 µm filter to remove particulate matter, if any. The filtered solutions were properly diluted for 
analysis as already described. The drug present in the sample solutions was calculated by using the calibration 
curves. All the solutions were stored at 2-8 ºC for future use. 
 
5. Method Validation 
5.1 Specificity 
The specificity of the HPLC method was determined by checking the interference of any of the possible 
degradation products and Absorbances produced during study of CF, CT. The study of the drug was carried out 
with Methanol, Triethylamine, Ultra Pure Water for discovering the stability nature of the drug. The degraded 
samples were prepared by taking suitable aliquots of the drug solution, and then undertaking the respective stress 
testing procedures for each solution. After the fixed time period, the stressed test solutions were diluted with the 
mobile phase. For every stress condition, a solution of concentration 50 µg\mL of  CF, CT was prepared. The 
specific stress conditions are described as follows. 
 
5.2 Linearity 
An twelve-point (0.1, 0.5, 1.0, 5.0, 10, 20, 30, 40, 50, 60, 70 and 80 µg\mL) calibration curves were prepared for 
the HPLC methods. The peak area for the HPLC was obtained by injecting 20 µl of the drug solution into the 
column. Calibration curves were plotted by taking the peak area curve on the y-axis and the concentration (µg \mL) 
on the x-axis. 
 
5.3 Precision 
The intraday and interday precision study was carried out to check the reproducibility of the results. A 
concentration of (15, 20, 25) µg\mL and 30 µg\mL of, CF, CT (n=3) were analyzed to find out relative standard 
deviation (RSD) for HPLC methods. 
 
5.4 Accuracy 
To check the accuracy of the proposed method, recovery studies were carried out at 80, 100, and 120% of the test 
concentration. The recovery study was performed three times at each level. The amount of CF, CT present in the 
sample was calculated using the calibration curves. 
 
5.5 Robustness 
The robustness of the HPLC method was studied by deliberately changing the method parameters like flow rate 
of the mobile phase, detection wavelength, and organic phase composition. A series of system suitability 
parameters like retention time, theoretical plates, and tailing factor were determined for each changed condition 
according to ICH [33].  
 
5.6 Limit of Detection and Limit of Quantitation 
The LOD and LOQ were determined separately according to the ICH guidelines. For the HPLC method, 
concentrations providing a signal-to-noise ratio 3:1 and 10:1 were considered as the LOD and LOQ, respectively. 
 
5.7 Results and Discussion 
Optimization of the mobile phase was carried out based on the tailing factor and theoretical plates obtained for CF, 
CT. During the trial runs, the drug was tested with different mobile phase compositions like (Triethylamine: Ultra 
pure water: Acetonitirle: Methanol v\v%) at various compositions (25:25:25:25 v\v%),(10:20:65:5 v\v%) ,and 
(10:20:68:2 v\v%) and flow rates (0.5,1.0, and 1.2 mL\min). The mobile phase consisting of Triethylamine: 
Methanol: Acetonitrile: Ultra Pure Water (2: 10: 20: 68 v\v%) at a flow rate of 1.0 ml\min was selected which gave 
a sharp, symmetric peak for CF, CT. The retention time for CF, CT was found to be (3.98, 3.67, 3.16 min) 
respectively. The run time was 5 min. The tailing factor for CF, CT was found to be (1.48, 1.43, 1.26). PDA 
detection was carried out at 265 nm. The separation was carried out at room temperature. Fig.3 (A), (B) 
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Respectively. 
 
Fig. 3. Chromatograms of CF, CT for Method (A), (B) Respectively 
5.8.1 Specificity 
To evaluate the specificity, a PDA detector was applied to find out the peak purity of the chromatographic peaks 
obtained for the stress-treated drug solution. Peak purity results are indicative for finding out the peak homogeneity. 
The specificity of the HPLC method was determined by checking the interference of any of the possible 
degradation products and Absorbances produced during study of CF, CT. The study of the drug was carried out 
with Methanol, Triethylamine, Ultra Pure Water for discovering the stability nature of the drug. The degraded 
samples were prepared by taking suitable aliquots of the drug solution, and then undertaking the respective stress 
testing procedures for each solution. The UV spectrums (Fig. 4) obtained for the blank and placebo show no 
interference due to the solvent used and presence of the commonly used excipients suggesting the specificity of 
the two methods. 
 
Fig. 4. UV Spectrum of Blank Solution (left) and of Placebo Solution (right) 
5.8.2 Linearity 
The calibration curves were found to be linear over a concentration range of 0.1–80 µg\mL for methods (correlation 
coefficient 0.999 for all the methods). The method parameters (overlay chromatograms) and regression 
data(Linearity series) are shown in (Fig. 5). (Fig. 6) Linearity of CF, (Fig. 7) Linearity of CT, Table 1 for regression 
data . 
 
Fig. 5. Overlay Chromatograms of CF, CT, linearity rang (0.1-80) µg\mL 
 
(A) (B) 
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Fig. 6. Linearity of CF (0.1-80) µg\mL                                Fig. 7. Linearity of CT (0.1-80) µg\mL 
 
Tab. 1. Analysis of method parameters and regression data 
Parameter Cefuroxime axetil, 
(CF) 
Cefixime trihydrate, 
(CT) 
Slope 0.199 × 10+6 0.185 × 10+6 
Intercept 0.205 × 10+6 0.065 × 10+6 
Correlation Coefficient 0.9995 0.9997 
Detection Wavelength, nm 265 
Linear rang, µg\mL 0.1-80 
5.8.3 Precision 
The methods were found to be precise as the RSD (%) values for the precision studies were well below 2% (n=3). 
The results are shown in Table 2. 
5.8.4 Accuracy 
The accuracy of the developed methods was found out by the standard addition method. High recovery values 
suggest that all three methods are accurate. The results are shown in Table 2. 
5.8.5 Limit of Detection and Limit of Quantitation 
The LOD and LOQ values shown in Table 2 suggest that the developed methods are sensitive to determine CF, 
CT. 
Tab. 2. Summary of validation parameters 
Parameter Accuracy(recover),% *Precision(RSD),%  LOD, µg/ml LOQ, µg/ml 
Cefuroxime axetil, (CF) 100.96% 0.28 0.87 2.66 
Cefixime trihydrate, (CT) 100.75% 0.98 0.67 2.05 
* Average of three determination at each level. 
5.8.6 Robustness 
The HPLC method was found to be robust under deliberate changes in the mobile phase flow rate (±0.1 mL/min), 
detection wavelength (±5 nm), and organic phase composition (±2%). The results of system suitability for the 
robustness study are shown in Table 2. For the UV spectroscopic methods, changing the slit width shows no 
significant effect on absorbance, indicating the robustness of the developed methods. No significant changes were 
obtained in the content of CF, CT during the solution stability studies by the developed methods. The recoveries 
for the solution stability by Method was found to be 100.96%, 100.75%, respectively. 
5.8.7 Analysis of Commercial Dry Syrup Formulation 
The developed methods were successfully applied for the determination of CF, CT in the Tablet, Capsule, dry 
Syrup formulation. The result for the assay of CF, CT is shown in Table 3. The assay results obtained for CF, CT 
in the syrup formulation using the HPLC and UV spectroscopic methods. 
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Tab. 3. Assay of syrup formulation 
Formulation Label Claim *RSD% Recovery(%)±SD 
Zinamed (125mg\5mL) 0.01 105.40±0.05 
Zednad (250mg\5mL) 0.38 105.13±0.19 
Zenamed (500mg\tab) 0.04 104.80±0.02 
Sopraxymed(100mg\5mL) 1.76 106.60±0.87 
Sopraxymed(200mg\5mL) 1.01 106.00±0.86 
Sopraxymed(400mg\Cap) 0.93 100.80±0.46 
* Average of three determination at each level. 
 
5.9 Conclusion 
Three novel analytical methods were developed for the determination of (CF, CT). The validation study shows the 
methods are specific, linear, precise, accurate, and sensitive in the proposed working range. The methods were 
found to be fast, simple, accurate, precise, and sensitive. The excipients present in the commercial formulation 
were found to be non-interfering in the assay results. The methods were successfully applied for the determination 
of the drug in dry syrup formulation. Furthermore, the developed methods may be applied for the routine analysis 
of the drug in API, formulations, and dissolution medium. 
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